CannMed 2017 | CannMed 2017 Schedule
CannMed 2017 features two full days of presentations from the greatest minds in medical cannabis.
page-template-default,page,page-id-920,ajax_fade,page_not_loaded,,qode_grid_1300,side_area_uncovered_from_content,qode-theme-ver-10.0,wpb-js-composer js-comp-ver-5.0.1,vc_responsive

Preliminary CannMed 2017 Conference Schedule

Monday April 10, 2017

7:30AM – 9:00AM
Coffee / Registration
9:00AM – 10:20AM

The Endocannabinoid System: A Fifty-Year Trip
Raphael Mechoulam Ph.D.


The Endocannabinoid System – A Source for Drug Discovery
Alexandros Makriyannis Ph.D.


Use of CB2 Receptor Inverse Agonists in the Treatment of Traumatic Brain Injury
Anton Reiner Ph.D.


Hydrogenated Cannabis Oil
Mark Scialdone Ph.D.

10:20AM – 10:40AM
Coffee Break
10:40AM – Noon

How Patients Benefit from Medical Cannabis
Bonni Goldstein MD


A Clinician’s Approach to Managing Uncertainty in Medically Refractory Patients
John Gaitanis MD


Cannabis Therapeutic Use in the Elderly
Deborah Malka MD


Portable genomics and the Open Source CNS (Cannabis Nomenclature System)
Kevin McKernan

Noon – 1:00PM
Lunch & Networking
1:00PM – 2:00PM

Jonathan Page Ph.D.


Nolan Kane Ph.D.


A Mother’s Story: What is the Drug War, Really?
Lyn Ulbricht

2:00PM – 2:20PM
Coffee Break
2:20PM – 3:50PM

The Role of Cannabidiol in the Treatment of Refractory Pediatric Epilepsy
Elizabeth Thiele MD


Cannabidiol (Epidiolex) in Dravet and Lennox-Gastaut Syndromes: Preliminary Clinical Trial Results
Orrin Devinsky MD


Toward Precision Medicine for Cannabidiol Treatment in Epilepsy, and the Impact of Rare Variation in Endocannabinoid System Genes
Douglas R. Smith Ph.D.


Potential Clinical Benefits of CBD-Enriched Extracts Over Purified CBD in Treatment-Resistant Epilepsy
Fabricio Pamplona Ph.D.

3:50PM – 5:30PM
Poster / Networking
5:30PM – 7:00PM
Red Carpet Movie Premier

“The Black Ghiandola”, a film co-written by Anthony Conti, a Walpole, MA teen who in January lost his battle with a rare form of adrenal gland cancer, which he partially treated with medical cannabis. The event will take place on April 10 at The Joseph B. Martin Conference Center at Harvard Medical School. The film was made possible thanks to the Make a Film Foundation — a nonprofit organization that grants film wishes to children with serious or life-threatening medical conditions by teaming them with noted actors, writers, directors, and producers who help them to create short film legacies.

Tuesday April 11, 2017

8:00AM – 9:00AM
Coffee / Registration
9:00AM – 10:30AM

Israel, Leading a Process: From Illegal Substance to Potent Medication
Michael Dor MD


A Personal Story
Amir Golan


Is Cannabis a Solution to the Opioid Epidemic?
Dustin Sulak DO


Jeffrey Hergenrather MD

10:30AM – 10:50AM
Coffee Break
10:50AM – Noon

Case Presentations of Cancer Patients Treated with Low Dose Cannabis Oil Alone or in Combination with Conventional Therapy
Debra Kimless MD


Matching an Effective Cannabis Strain Extract for a Specific Subtype of Cancer
David Meiri Ph.D.


Comparison of the Anti-Tumor Efficacy of a Whole-Plant Extract vs. Pure THC in Preclinical Models of HER2-Positive Breast Cancer
Mara Gordon


Cannabinoids as Antitumor Agents: Moving Toward the Clinic
Sean McAllister

Noon – 1:00PM
Lunch & Networking | Healthcare Provider Legal Roundtable Session
1:00PM – 2:20PM

Cannabinoids as Medicine: Pain and CNS Injury
Sara Jane Ward Ph.D.


Impact of Standardized Cannabis Therapy in Chronic Noncancer Pain with or without Opiate Use
Kent Crowley Pharm.D.


Cannabis for Pain Management and Opioid Use Reduction
Jordan Tishler MD


Panel Discussion: Cannabis as Medicine in Professional Sports
moderated by Jim McAlpine

2:20PM – 2:40PM
Coffee Break
2:40PM – 4:00PM

It’s Not Easy Being Green: Assessing the Impact of Medical Marijuana on Cognition, Mood, Brain Function and Related Measures
Staci Gruber Ph.D.


Automation Solutions for High Throughput Pesticides Analysis in Cannabis Labs
Ryan Ravenelle Ph.D.


Cannabis Contaminants: Practical Considerations VS. Regulatory Requirements
Christopher Hudalla Ph.D.

Event Closing